These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 840159

  • 1. Neurotoxicity due to CNS therapy for leukemia.
    Pochedly C.
    Med Pediatr Oncol; 1977; 3(1):101-15. PubMed ID: 840159
    [Abstract] [Full Text] [Related]

  • 2. Excessive spinal cord toxicity from intensive central nervous system-directed therapies.
    Watterson J, Toogood I, Nieder M, Morse M, Frierdich S, Lee Y, Moertel CL, Priest JR.
    Cancer; 1994 Dec 01; 74(11):3034-41. PubMed ID: 7954266
    [Abstract] [Full Text] [Related]

  • 3. Superiority of conventional intrathecal methotrexate therapy with maintenance over intensive intrathecal methotrexate therapy, unmaintained, or radiotherapy (2000-2500 rads tumor dose) in treatment for meningeal leukemia.
    Sullivan MP, Humphrey GB, Vietti TJ, Haggard ME, Lee E.
    Cancer; 1975 Apr 01; 35(4):1066-73. PubMed ID: 803866
    [Abstract] [Full Text] [Related]

  • 4. Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.
    Schrappe M, Reiter A, Henze G, Niemeyer C, Bode U, Kühl J, Gadner H, Havers W, Plüss H, Kornhuber B, Zintl F, Ritter J, Urban C, Niethammer D, Riehm H.
    Klin Padiatr; 1998 Apr 01; 210(4):192-9. PubMed ID: 9743952
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Central nervous system pharmacology of antileukemic drugs.
    Balis FM, Poplack DG.
    Am J Pediatr Hematol Oncol; 1989 Apr 01; 11(1):74-86. PubMed ID: 2496615
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of overt CNS leukemia.
    Humphrey GB, Krous HF, Filler J, Maxwell JD, VanHoutte JJ.
    Am J Pediatr Hematol Oncol; 1979 Apr 01; 1(1):37-47. PubMed ID: 396791
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The central nervous system in childhood leukemia. II. Subacute leukoencephalopathy.
    Price RA, Jamieson PA.
    Cancer; 1975 Feb 01; 35(2):306-18. PubMed ID: 1089469
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Histopathology of CNS leukemia and complications of therapy.
    Price RA.
    Am J Pediatr Hematol Oncol; 1979 Feb 01; 1(1):21-30. PubMed ID: 396790
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Therapy of CNS leukemia with intraventricular chemotherapy and low-dose neuraxis radiotherapy.
    Steinherz P, Jereb B, Galicich J.
    J Clin Oncol; 1985 Sep 01; 3(9):1217-26. PubMed ID: 3861774
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cranial computed tomography during treatment of childhood lymphocytic leukemia. Factors predisposing to abnormalities.
    Clausen N, Pedersen H.
    Acta Paediatr Scand; 1982 Mar 01; 71(2):257-62. PubMed ID: 6958174
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.